These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Frequency of relapse of pulmonary tuberculosis in CAD (Central Antituberculous Dispensatory) in Nis during the period , 1965-1967]. Panajotović H Plucne Bolesti Tuberk; 1970; 22(1):70-5. PubMed ID: 5538345 [No Abstract] [Full Text] [Related]
43. Leads from the MMWR. Multi-drug-resistant tuberculosis--North Carolina. JAMA; 1987 Feb; 257(6):743-4. PubMed ID: 3806846 [No Abstract] [Full Text] [Related]
45. Primary drug resistant tuberculosis in Puerto Rico. Zack MB; Figueroa-Lebrón RE Bol Asoc Med P R; 1974 Nov; 65(11):262-6. PubMed ID: 4217187 [No Abstract] [Full Text] [Related]
46. [Results of examinations at admission time to the study of fibrous lesions and pulmonary tuberculosis]. Krebs A Bull Int Union Tuberc; 1974; 49(1):313-8. PubMed ID: 4219730 [No Abstract] [Full Text] [Related]
47. [Specific serum antimycobacterial activity test in pulmonary tuberculosis patients]. Yamagata Y; Konomata T Iryo; 1966 May; 20(5):450-5. PubMed ID: 5963052 [No Abstract] [Full Text] [Related]
48. [Antimycobacterial therapy in processes caused by primarily resistant bacteria]. De Michele G Arch Monaldi; 1972; 27(4):487-94. PubMed ID: 4680310 [No Abstract] [Full Text] [Related]
49. Multi-drug resistant tuberculosis in migrants. Pang SC; Gill JS Aust N Z J Med; 1991 Aug; 21(4):457-9. PubMed ID: 1953538 [TBL] [Abstract][Full Text] [Related]
50. Anti-tuberculosis drug resistance in new and previously treated pulmonary tuberculosis cases in Burkina Faso. Sangaré L; Diandé S; Badoum G; Dingtoumda B; Traoré AS Int J Tuberc Lung Dis; 2010 Nov; 14(11):1424-9. PubMed ID: 20937182 [TBL] [Abstract][Full Text] [Related]
52. The tuberculosis X factor. Lancet Infect Dis; 2006 Nov; 6(11):679. PubMed ID: 17067912 [No Abstract] [Full Text] [Related]
53. The seventh nationwide tuberculosis prevalence survey in Korea, 1995. Hong YP; Kim SJ; Lew WJ; Lee EK; Han YC Int J Tuberc Lung Dis; 1998 Jan; 2(1):27-36. PubMed ID: 9562108 [TBL] [Abstract][Full Text] [Related]
54. [Preliminary clinical observations on the use of Rifampicin in chronic cavitary pulmonary tuberculosis previously treated with and resistant to other drugs]. Mauro G Arch Tisiol Mal Appar Respir; 1968 Jun; 23(6):461-6. PubMed ID: 5309059 [No Abstract] [Full Text] [Related]
55. [Results of the treatment in patients with pulmonary tuberculosis excreting bacilli in primary resistance to antitubercular drugs]. Hornung S; Polończyk M Gruzlica; 1965 Oct; 33(10):886-9. PubMed ID: 5881604 [No Abstract] [Full Text] [Related]
56. [2 cases of drug-resistant pulmonary tuberculosis treated with ofloxacin]. Krasucka-Kluźniak A; Krakówka P Pneumonol Pol; 1989 Apr; 57(4):249-52. PubMed ID: 2516906 [TBL] [Abstract][Full Text] [Related]
57. [Present status of infection and development of tuberculosis in Japan. Some results mainly obtained at the occasions of tuberculosis epidemics]. Kekkaku; 1988 Dec; 63(12):791-812. PubMed ID: 3226034 [No Abstract] [Full Text] [Related]
58. [Pulmonary tuberculosis and primary bacterial resistance to antibacillary drugs]. Cazes M Torax; 1967 Dec; 16(4):222-30. PubMed ID: 5620686 [No Abstract] [Full Text] [Related]
59. International Conference on Tuberculosis. Summary. Global problems of tuberculosis. Bates JH Chest; 1979 Dec; 76(6 Suppl):816-7. PubMed ID: 510029 [No Abstract] [Full Text] [Related]